Laurent Humeau - 26 Feb 2022 Form 4 Insider Report for INOVIO PHARMACEUTICALS, INC. (INO)

Role: Chief Scientific Officer
Signature: /s/ Laurent Humeau
Issuer symbol: INO
Transactions as of: 26 Feb 2022
Net transactions value: -$27,515
Form type: 4
Filing time: 01 Mar 2022, 17:48:43 UTC
Previous filing: 11 Aug 2021
Next filing: 09 Mar 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	INO	Common Stock	Options Exercise		+22,545	+33%		91,132	26 Feb 2022	Direct	F1
transaction	INO	Common Stock	Tax liability	$27,515	-8,545	-9.4%	$3.22^*	82,587	26 Feb 2022	Direct	F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	INO	Restricted Stock Unit	Options Exercise	$0	-22,545	-33%	$0.000000	45,088	26 Feb 2022	Common Stock	22,545		Direct	F1
transaction	INO	Common Stock Option	Award	$0	+186,000		$0.000000	186,000	26 Feb 2022	Common Stock	186,000	$3.22	Direct	F3
transaction	INO	Restricted Stock Unit	Award	$0	+138,800		$0.000000	138,800	26 Feb 2022	Common Stock	138,800		Direct	F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 67,633 restricted stock units is as follows: 22,545 shares vested on February 26, 2022; 22,544 shares will vest on February 26, 2023; 22,544 shares will vest on February 26, 2024. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both.
F2	The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting and settlement of the restricted stock unit award reported in footnote (1) herein.
F3	The vesting schedule for the 186,000 options is as follows: 46,500 shares vested on February 26, 2022; 46,500 shares will vest on February 26, 2023; 46,500 shares will vest on February 26, 2024; 46,500 shares will vest on February 26, 2025.
F4	Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 138,800 restricted stock units is as follows: 46,267 shares will vest on February 26, 2023; 46,267 shares will vest on February 26, 2024; 46,266 shares will vest on February 26, 2025. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both.